{"id":"csl-112","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"CSL_112 works by inhibiting the complement system, which is a part of the immune system that helps to clear pathogens from the body. By inhibiting the complement system, CSL_112 aims to reduce inflammation and prevent tissue damage.","oneSentence":"CSL_112 is a recombinant human monoclonal antibody that targets the complement system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:29:39.059Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Paroxysmal nocturnal hemoglobinuria (PNH)"}]},"trialDetails":[{"nctId":"NCT02742103","phase":"PHASE2","title":"A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2016-08","conditions":"Acute Myocardial Infarction, Moderate Renal Impairment","enrollment":83}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CSL_112","genericName":"CSL_112","companyName":"CSL Behring","companyId":"csl-behring","modality":"Biologic","firstApprovalDate":"","aiSummary":"CSL_112 is a recombinant human monoclonal antibody that targets the complement system. Used for Paroxysmal nocturnal hemoglobinuria (PNH).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}